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Orthologs of the pentameric receptor channels that mediate fast synaptic transmission in the central and
peripheral nervous systems have been found in several bacterial species and in a single archaea genus.
Recent X-ray structures of bacterial and invertebrate pentameric receptors point to a striking conservation
of the structural features within the whole family, even between distant prokaryotic and eukaryotic members.
These structural data reveal general principles of molecular organization that allow allosteric membrane
proteins tomediate chemoelectric transduction. Notably, several conformations have been solved, including
open and closed channels with distinct global tertiary and quaternary structure. The data reveal features of
the ion channel architecture and of diverse categories of binding sites, such as those that bind orthosteric
ligands, including neurotransmitters, and those that bind allosteric modulators, such as general anesthetics,
ivermectin, or lipids. In this review, we summarize the most recent data, discuss insights into the mechanism
of action in these systems, and elaborate on newly opened avenues for drug design.The concept of a pharmacological receptor can be traced back
more than a hundred years ago to the works of Paul Ehrich
and, particularly, John Newport Langley (Langley, 1905), who
observed that the neuromuscular junction, whose neurotrans-
mitter is acetylcholine (ACh), was the site of action for nicotine
and curare. Langley demonstrated that nicotine behaves as an
agonist, causing a contraction of the striated muscles, and that
curare, on the other hand, behaves as a competitive antagonist
by directly blocking it. Themechanism of signal transduction that
results in the opening of a cation selective ion channel (Katz and
Miledi, 1966) is a conformational change of the nicotinic acetyl-
choline receptor (nAChR), the first neurotransmitter receptor
and ion channel ever isolated (Changeux et al., 1970; Miledi
et al., 1971; Corringer et al., 2000; Karlin, 2002; Changeux and
Edelstein, 2005). Subsequent studies revealed that the brain
receptors for the neurotransmitters g-aminobutyric acid (GABA),
glycine, and serotonin, also known as 5-hydroxytryptamine
(5-HT), form a common family with homologous primary, tertiary,
and quaternary structures (Betz, 1990; Miller and Smart, 2010).
This important family of ligand-gated ion channels (LGIC) was
referred to first as nicotinic, then cys-loop, and finally as pen-
tameric LGIC (pLGIC) to contrast with the tetrameric receptor
channels for glutamate and the trimeric receptor channel for ATP.
pLGICs are widely expressed in multicellular animals (meta-
zoans) from invertebrates including insects and worms to fish
including Torpedo and zebrafish, as well as mammals and
humans. pLGICs have been extensively studied from both struc-
tural (Cartaud et al., 1973; Brisson and Unwin, 1985; Mitra et al.,Str1989; Unwin, 2005) and pharmacological points of view
(Changeux and Edelstein, 2005; Dent, 2010). In 2005, sequences
of putative pLGICs orthologs were identified in genomes of a few
bacterial species (30 among more than 1000 sequenced
genomes) as well as the archaea Methanosarcina (Tasneem
et al., 2005). It was then discovered that the expression of the
coded protein from one of the species, Gloeobacter violaceus,
yields functional cationic ligand-gated ion channels (Bocquet
et al., 2007). Furthermore, these bacterial receptors provided
the first high-resolution structures of a full-length ligand-gated
ion channel (Hilf and Dutzler, 2008, 2009; Bocquet et al., 2009)
(Figure 1A). The first structure of an eukaryotic member of the
family, the anionic glutamate receptor from C. elegans (GluCl),
was recently solved at atomic resolution (Hibbs and Gouaux,
2011). The aim of this review is to present and discuss the
remarkable structural homologies between these prokaryotic
and eukaryotic pLGICs and to investigate the extent to which
these allosteric membrane proteins may serve as models for
designing drugs that target brain neurotransmitter receptors.
Homology of Primary Sequence between Prokaryotic
and Eukaryotic Pentameric Receptors: A Plausible
Phylogenetic Scenario
The amino acid sequences of eukaryotic pLGICs and putative
prokaryotic pLGICs show low sequence identity of typically
18%–20%, reflecting their phylogenetic distance. However,
they clearly share common key features that support the view
that they are authentic orthologs. First, they possess a commonucture 20, June 6, 2012 ª2012 Elsevier Ltd All rights reserved 941
Figure 1. X-Ray Structures and Allosteric Functional Model for
Pentameric Ligand-Gated Ion Channels
(A) Structures of AChBP, ELIC, GLIC, and GluCl in cartoon representation in
side view and in upper view (with TMD only for clarity). Note the high
conservation of the ECD folded in b sandwich and of the TMD composed of
four a helices. Eukaryotic pLGICs contain a highly variable intracellular domain
between M3 and M4 and some prokaryotes are fused at their N terminus to
other bacterial periplasmic proteins. In the four structures, the b sandwich core
of the ECD constitutes a rigid block with a rmsd of about 0.5 A˚ when pair-
superimposed on one subunit. At the level of the pentamer, comparison of the
ECD of AChBP, ELIC, andGluCl shows a good superimposition (rmsd of 0.8 A˚),
while the b sandwich core of GLIC is rotated by 8 as compared to the other
(Bocquet et al., 2009). Concerning the TMD, ELIC shows a closed channel
while GLIC and GluCl display an open channel.
(B) Five-state allosteric scheme for pLGIC functioning, implicating major
basal, active, and desensitized states together with intermediate and fast
desensitizing states inferred from functional experiments. Direct isomerization
between nonadjacent states, as predicted by the MWC theory, is not repre-
sented for clarity. At present, GLIC and GluCl structures are used as models of
the active state, and the ELIC-corresponding state is unknown.
Figure 2. Subunit Topology and Highly Conserved Residues in the
pLGIC Family in the Context of GLIC and GluCl Structures
a helices are shown as cylinders and b strands as arrows. The ‘‘core’’ of the
subunits, corresponding to the highly conserved fold among the know struc-
tures, is colored in yellow, while more variable regions are in blue (note the
insertion of a residue stretch in b5 and helix a1 in GluCl as compared to GLIC).
In the ECD, a concentration of conserved residues (red circles) is present at the
tip of the subunit. TheWXPDmotif (near loopA) interacts with another Trp (near
Loop D), itself linked to a conserved Gly via a Val (near loop E). The conserved
cysteine bridge constrains the conformation of loop 7 at the ECD/TMD
interface, which carries the canonical FPFD motif (where F stands for an
aromatic residue). Other conserved residues include a proline in the M2-M3
loop, a proline in M1 producing a conserved kink, and a highly correlated
simultaneous presence/absence of three motifs in subfamilies (light blue
circles) that are interacting together, notably through a characteristic stacking
interaction between Trp (from M1) and Arg (from M4).
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Second, the analysis of multiple sequence alignments reveals
that a few residues or motifs are conserved, both in the extracel-
lular and transmembrane segments. These conserved motifs
(Figure 2) are considered necessary for structure and function
of pLGICs.942 Structure 20, June 6, 2012 ª2012 Elsevier Ltd All rights reservedFrom an evolutionary point of view, the known prokaryotic
genes show the highest diversity in sequence, plausibly associ-
ated with a highly sporadic distribution within bacterial species.
Only 3% of all bacteria sequenced so far contain a putative
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including cyanobacteria and proteobacteria. The observed
diversity suggests a high degree of genetic mobility through
lateral transfer and frequent gene loss (Tasneem et al., 2005)
and a large repertoire of functional properties. In contrast, meta-
zoan pLGICs sequences are closer to each other and show
a highly stereotypic architecture. They split into two major fami-
lies corresponding to the ACh-serotonin type receptors (usually
cationic) and glycine-GABA type receptors (usually anionic). The
diversification of prokaryotic forms thus preceded the emer-
gence of eukaryotic forms. Interestingly, a particular subgroup
of bacterial pLGICs, for example, from G. violaceus and Erwinia
chrysanthemi, display striking sequence similarity to the eukary-
otic pLGICs when compared to the other bacterial pLGICs. One
may thus suggest a phylogenetic scenario in which these
pLGICs would be the ancestors of the eukaryotic neurotrans-
mitter receptors branch.
Comparison of Prokaryotic and Eukaryotic Pentameric
Receptors Structures at the Atomic Level
Despite sequence divergences, structural data available for
various members of the family point to high conservation of the
3D structure, with an inner core virtually unaltered from the
receptors of bacteria to those of higher vertebrates. Available
structures include those of prokaryotic channels from
G. violaceus GLIC and E. chrysanthemi ELIC solved at 2.9 A˚
(Bocquet et al., 2009) and 3.3 A˚ (Hilf and Dutzler, 2008, 2009),
respectively, and eukaryotic channel GluCl from C. elegans (in
complex with a Fab and ivermectin) solved at 3.3 A˚ resolution
(Hibbs and Gouaux, 2011), as well as electron microscopy
(EM) structure of Torpedo nAChR (TnAChR) at 4–9 A˚ resolution
(Unwin, 1995; Miyazawa et al., 2003). All these structures of
both prokaryotic and eukaryotic receptors share a common
organization with a molecular mass of 150–300 kDa, comprising
five identical or homologous subunits symmetrically arranged
around a central ionic channel with a C5 axis perpendicular to
the membrane plane. All of the structures show the same orga-
nization of the constitutive subunits into extracellular domain
(ECD) and transmembrane domain (TMD) (Figure 1A). Moreover,
in several instances, these two domains can be independently
expressed and folded as isolated units, illustrating their respec-
tive folding autonomy.
ECD
Several X-ray structures of the isolated ECD have been solved:
the pentameric acetylcholine binding protein (AChBP) homolog
in complex with a variety of nicotinic ligands, at up to 2.05 A˚ reso-
lution (Brejc et al., 2001; Bourne et al., 2005, Hansen et al., 2005,
Hibbs et al., 2009; Rucktooa et al., 2009; Brams et al., 2011a);
ECD of GLIC at 2.3 A˚ (Nury et al., 2010a); ECD of the a1nAChR
subunit in complex with a-bungarotoxin at 1.94 A˚ (Dellisanti
et al., 2007); and a7nAChR/AChBP chimera with and without
an agonist at 2.8 and 3.1 A˚ (Li et al., 2011; Nemecz and Taylor,
2011). Consistent with structural studies of AChBP (Brejc et al.,
2001), ECD of all prokaryotic and eukaryotic pentameric recep-
tors are folded in a highly conserved immunoglobulin-like b sand-
wich stabilized by inner hydrophobic residues. On the other
hand, the connecting loops, as well as an N-terminal a helix
present in most eukaryotic pLGICs, are variable in length and
structure (see Figure 2). To date, the role of this N-terminal a helixStrfound only in eukaryotes remains unknown, although recent
evidence shows that this segment contributes to receptor
expression and to recognition by antibodies, especially autoan-
tibodies found in myasthenia gravis patients (Luo et al., 2009).
TMD
Consistent with early structures of Torpedo nAChR (Unwin,
2005) at medium resolution (more than 4 A˚), the four transmem-
brane segments fold into a helices and are organized as a well-
conserved bundle. The second segment, M2, lines the channel
walls (Giraudat et al., 1986, 1987; Hucho et al., 1986; Imoto
et al., 1986, 1988) and is surrounded by a ring of a helices
made of M1 andM3. M4 lies at the side of the tight a helix bundle
made of segments M1 to M3 and interacts extensively with the
lipid bilayer. Interestingly, the structure of GLIC reveals three
lipid molecules per subunit that are bound in the crevices
between M4 and either M1 or M3 (Figure 5) (Bocquet et al.,
2009; Nury et al., 2011).
In the case of the b2 nAChR subunit, NMR studies show that
the TMD four a helix bundle may fold in isolation in a manner
similar to that occurring in the full-length protein (Bondarenko
et al., 2010). Moreover, association of M4 with the bundle
composed of M1-M3 a helices is required for receptor folding
because a glycine receptor lacking M4 does not fold into
a pentamer and is rescued by coexpression of the M4 a helix
(Villmann et al., 2009; Haeger et al., 2010).
ECD-TMD Interface
The major loop contributing to the ECD-TMD interface, namely
loop 7, which carries the canonical FPFD motif, is not ordered
in the isolated GLIC ECD structure while it adopts a well-folded
structure through its extensive set of interactions with the TMD
four a helix bundle in the full-length GLIC (Nury et al., 2010a)
(Figure 2). This particularly well-conserved featuremight account
for the striking observation that ECDs and TMDs from different
pentameric receptor species can be coupled to form functional
receptors; for example, functional ECD-TMD chimera among
eukaryotic a7, a4, and b2 nACh and 5HT3 receptors (Eisele´
et al., 1993; Cooper et al., 1999) and a7nACh and a1Glycine
receptors (Grutter et al., 2005) have been reported. Recently,
fully functional chimeras have also been constructed between
bacterial GLIC and a1Glycine receptor (Duret et al., 2011), further
demonstrating the remarkable conservation of the functional
organization of the receptors.
Superposition of GluCl and GLIC structures reveals striking
similarities but differences can be found in residues distributed
at the subunit-subunit interfaces including (Figure 2) (1) the
b8b9 Loop (Loop F, see below) located on the outside of the
ECD, and (2) an insertion in strand b5 that is specific to GluCl
structure and faces the inner part of the ECD. The former region
is important for ligand binding (Bourne et al., 2005) and the latter
for a possible concerted movement of the oligomer (see below)
and Zinc modulation (Miller et al., 2008).
‘‘Orthosteric’’ Ligand Binding Sites: Homologies
between Prokaryotic and Eukaryotic Neurotransmitter
Binding Sites
Within the whole family, the best functionally characterized
orthosteric binding site is that of nAChRs. Early affinity labeling
experiments followed by extensive mutagenesis have demon-
strated that the ACh binding site lies at the interface betweenucture 20, June 6, 2012 ª2012 Elsevier Ltd All rights reserved 943
Figure 3. 3D Structure of the ECD and the Orthosteric Binding Site
Cartoon representation in side views of GLIC, LS-AChBP, and GluCl. Subunits are orientated to show their complementary (View 1) and principal (View 2)
interface. Highly conserved residues are in red. The loops A–G contributing to the orthosteric binding site are colored as defined in the top left panel. Cavities
composing (dark brown) or neighboring (light brown) the orthosteric (neurotransmitter) binding site are represented as surfaces. Bound ligand (glutamate for
GluCl, nicotine for AChBP) are represented with balls and sticks, contoured in yellow.
The conservedFPFDmotif of loop 7, highlighted in GLIC, is in ‘‘helix-like’’ interaction with the C terminus of M3 (not shown), effectively extending this helix in the
ECD. This is allowed by the cis conformation of the proline, which is stabilized by stacking interaction with the two neighboring aromatic residues. The aspartate
ending the motif forms an ion pair with a conserved arginine at the junction between ECD and TMD, thus providing another anchor for loop 7.
The conserved residues at the tip of the ECD (highlighted onGluCl) appear as a ‘‘stabilizing box’’ that holds together the two sheets of the sandwichwhile orienting
the loops of the orthosteric site. A Trp from loop D interacts with the Trp from theWXPDmotif near loop A through a typical edge-to-faced configuration (Samanta
et al., 1999; Guvench and Brooks, 2005). Both Trp are necessary for receptor folding (Spier and Lummis, 2000), and interact with the proline of the WXPD motif,
either in a ‘‘L-shaped’’ or ‘‘stacked-like’’ favorable configuration (Biedermannova et al., 2008).
The shape of the ‘‘conserved/canonical’’ aromatic box from the principal subunit, highlighted on LS-AChBP, is constrained by a set of conserved interactions that
circularly involve loops A and B, strand b1, and the stabilizing box mentioned above. The conformation of loop B is conserved in GluCl, AChBP, and ELIC, but not
in GLIC, where interactions between the stabilizing box and loop B are broken. In GLIC, loop B adopts a conformation that occludes the cavity and positions an
Arg at the ligand site.
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subunit, named loops A, B, and C, and from four regions of
a ‘‘complementary’’ subunit, named loops D, E, F, and G
(Corringer et al., 2000) (Figure 3). The subsequently described
structure of the ACh binding site in AChBP (Brejc et al., 2001)
confirms these data, though the nomenclature becomes some-
what confusing because ‘‘loops’’ E and D are actually made of
residues from adjacent b strands and not from loop structures
(Brejc et al., 2001). Loops A (Tyr), B (Trp), C (two Tyr), and944 Structure 20, June 6, 2012 ª2012 Elsevier Ltd All rights reservedD (Trp) form an aromatic ‘‘box’’ chelating the quaternary
ammonium moiety of ACh, among whose Trp from loop B elicits
a direct cation-p interaction with the quaternary amine group of
ACh (in the case of muscle-type nAChR) (Zhong et al., 1998).
Unnatural amino acid mutagenesis further shows that the extent
of cation-p interaction critically contributes to the ligand binding
affinity and, notably, is responsible for the high affinity of nicotine
for the neuronal a4b2 (versus muscle-type) nAChRs (Xiu et al.,
2009). These experiments also allow a detailed mapping of
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et al., 2010). The acetyl portion of ACh interacts with loops
E and F that are highly variable in sequence among nAChRs.
At present, more than 50 structures of AChBP with various
bound ligands (Rucktooa et al., 2009) including agonists such
as nicotine (Celie et al., 2004), partial agonists such as anabasein
(Hibbs et al., 2009), and antagonists such as d-tubocurarine and
a-cobratoxin (Bourne et al., 2005; Brams et al., 2011b) have been
published. All AChBP structures display the same conformation,
with the notable exception of the ‘‘clamping’’ C loop because its
shape adapts to the size of the ligands. Binding of small
molecules such as nicotine and other agonists fits with a
‘‘capped’’ C loop characterized by an inward motion toward
the protein with a contraction of the binding site, while large
compounds,most often antagonists such as three-fingera toxins
from snakes, are associated with an ‘‘uncapped’’ C loop confor-
mation characterized by its outward motion, allowing sufficient
space for ligand binding.
The structure of the full-length eukaryotic GluCl receptor in
complex with the agonists glutamate shows that the ammonium
moiety is bound to aromatic residues from loop A (Phe), B (Tyr),
and C (Tyr), whereas the lateral carboxylate moiety interacts
mainly with Arg and Lys from loops D and F of the complemen-
tary component. Recently, the prokaryotic ELIC has been found
activated by a variety of primary amines including amino-
butanol, cysteamine, putrescine, and by high (in the millimolar
range) concentrations of the neurotransmitter GABA (but not
b-alanine and glycine) (Zimmermann and Dutzler, 2011). Cocrys-
tallization of ELIC in complex with bromopropylamine yielded
a 4 A˚ resolution structure, which shows that this compound
does indeed bind to the orthosteric binding site. While the
3.3 A˚ resolution structure of ELIC does not include GABA, the
data are consistent with the notion that the ammonium portion
of GABA is also bound by an aromatic box made up of loop
B (Phe) and C (Phe and Tyr), the carboxylate end contacting
the complementary component through Loop F (Zimmermann
and Dutzler, 2011).
Overall, an amazing similarity of structures emerges from
comparison of the various modes of neurotransmitter binding:
the primary/tertiary/quaternary amine moieties interact with an
aromatic box (as recently established by unnatural amino acid
mutagenesis; Pless et al., 2011), whereas the opposite ends of
the ligands interact with the more variable complementary
component (Hibbs et al., 2009).
The Ion Channel: Common Permeation and Selectivity
Mechanisms
The net output of pLGIC activation is the opening of the ion
channel, thereby eliciting cell excitation (cationic permeation),
inhibition (anionic permeation), or metabolic signaling (calcium
permeation). Early electrophysiological experiments with
eukaryotic pLGICs with cationic channels such as muscle
receptor typically revealed a poor discrimination among mono-
valent cations (Katz and Miledi, 1966; Colquhoun and Sakmann,
1998). These channels therefore primarily screen for charge
rather than for a specific ion radius, in contrast to what is
observed with the highly selective potassium channels exempli-
fied by KcsA (Doyle et al., 1998). Abundant biochemical,
biophysical, and mutational data have further demonstratedStrthat the ion permeation pathway encompasses the full-length
structure of pLGICs and involves topographically distinct
elements from those involved in ligand binding. They include
the extracellular vestibule (Hansen and Taylor, 2007; Brams
et al., 2011a; Moroni et al., 2011), the intracellular domain
(Carland et al., 2009), and the transmembrane channel itself,
which is the dominant determinant of ion permeation and selec-
tivity (Giraudat et al., 1986; Hucho et al., 1986; Imoto et al., 1986,
1988; Changeux and Edelstein, 2005). Both extra- and intracel-
lular compartments contribute to ionic conductance, mainly by
providing an electrostatic potential of opposite sign to that of
the permeant ion, the selectivity filter for charges being located
at the bottom part of the M2 transmembrane segment (Konno
et al., 1991, Galzi et al., 1992; Corringer et al., 1999) (Figure 4).
The systematic construction of chimeras between the cationic
a7-nAChR and the anionic a1-GlyR identified two key amino
acids involved in ion selection: cationic channels carry a ring of
negatively charged residues at position 10 or 20 (the prime
numbering originates at the N-terminal end of the M2 segment
with Lys238 of a7-nAChR and Arg252 of a1-GlyR corresponding
to the 00 position), whereas the anionic channels lack these resi-
dues but contain an additional residue as compared to cationic
channels, typically a proline, at position 20 (Galzi et al., 1992).
Similar findings were reported with 5-HT3A receptor (Gunthorpe
and Lummis, 2001). Conversely, switching glycine receptor and
GABAC channel selectivity from anionic to cationic was achieved
by carrying out the reverse substitutions but was also partially
achieved with only the introduction of a ring of negatively
charged residues (Keramidas et al., 2000, 2002). Concordant,
yet not identical, results are thus found within the various
members of the eukaryotic pLGICs family (Taly et al., 2009; Miller
and Smart, 2010).
The structures of prokaryotic GLIC and of eukaryotic GluCl
offer a unique opportunity to examine the architecture of
a cationic versus anionic channel. Both structures were solved
in the presence of agonist (protons and glutamate/ivermectin,
respectively) and show a highly conserved pore architecture
characterized in the extracellular part by a large diameter
(12 A˚) and, in the cytoplasmic part, by a narrow constriction
(5 A˚ in diameter) composed of three rings of residues at position
60, 20 and 20 (and not 10 as classically assumed; Konno et al.,
1991, Galzi et al., 1992, Keramidas et al., 2000) (Figure 4). This
geometry agrees well with that suggested for an open channel
conformation in eukaryotic nAChRs (Wilson and Karlin, 1998;
Corringer et al., 1999; Cymes et al., 2005) and the three rings
at 60, 20 and 10 were already known to contribute to the
‘‘selectivity filter’’ portion of the channel, based on permeation
and mutational studies (Villarroel et al., 1991; Galzi et al., 1992;
Villarroel and Sakmann, 1992; Wilson and Karlin, 1998; Corringer
et al., 2000). In both GLIC and GluCl ‘‘open’’ structures, the pore
narrows down at this level and creates binding sites for ions such
as Cs+ (near 20 position), Zn2+ (near 10 position), and Cd2+
(between 10 and 20) for GLIC (Hilf et al., 2010) (see Figure 3).
In the GLIC structure (Bocquet et al., 2009), the ring of Glu
residues at position20 and located at the cytoplasmic entrance
to the pore is found in two conformations, one exposed to the
outside and one exposed to the pore. This suggests that, in
addition to its electrostatic contribution, it could ‘‘pick up’’ ions
within the pore. Molecular dynamics simulations support theucture 20, June 6, 2012 ª2012 Elsevier Ltd All rights reserved 945
Figure 4. Cation and Anion Density Predicted by Electrostatics Calculations Show a Mirror-like Distribution for GLIC and GluCl
Lateral panels show a single subunit of GLIC (left) and GluCl (right) with conserved residues shown in red and residues bordering the ion permeation pathway in
yellow (their nature and sequence number is further displayed in white on the density plots). Electrostatic properties of the channel lumen computed according to
Azuara et al. (2008) and Koehl and Delarue (2010) are presented by plotting the cation (left) and anion (right) densities colored according to the central scale, for
both GLIC and GluCl, which are respectively permeant to cations and anions. A mirror-like distribution of ion types arises throughout the entire permeation
pathway (but note that both structures lack an intracellular domain). The electrostatics of the pore seems to bemainly determined by the charge of residues at the
intracellular entrance (numbered 20 and 00). Identified binding sites for several chemical compounds are displayed on the sides in yellow letters.
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(E-20), the two conformers occurring in an asymmetric fashion
with respect to the pentameric symmetry, plus they identify
a third intermediate conformer (Fritsch et al., 2011). Calculation
of potential of mean force profiles based on the GLIC structure
suggests that its preference for Na+ compared to Cl arises
both from E-20 and an overall environment providing negative
electrostatic potential in the pore favoring the passage of Na+
while hindering translocation of Cl (Fritsch et al., 2011).
By comparison, in the GluCl structure, the proline at
position 20 in M2 produces a local reorganization of the short
loop linking M1 and M2 as predicted from mutational analysis
(Corringer et al., 1999). A recent study (Cymes and Grosman,
2011) proposes a rationale for this observation. Most pLGICs
carry a Lys or Arg at position 00 with a side chain that protrudes
toward the subunit interior far from the channel. Single-channel
recordings suggest that this ring of Lys/Arg is not charged
(protonated) at pH 7 in cationic pLGICs (note that it is a Asn in
GLIC), probably because of a high hydrophobic environment,
whereas it is partially charged in anionic pLGICs, providing an
electropositive field attracting anions. It is therefore possible
that the proline insertion, by provoking a local reorganization
such as the one observed in the X-ray structure, generates
a more polar environment for the guanidinium moı¨ety that would
favor its protonation. These observations thus suggest that
a subtle structural reorganization of the cytoplasmic border of
M2, conferred by a single proline insertion, contributes to anionic
conductance within the family.
The ion channel is also the binding site for blockers, which
inhibit ion flux through steric plugging of the channel. Extensive
affinity labeling with TnAChR identified early on the bundle of
M2 segments as constituting the binding sites for channel946 Structure 20, June 6, 2012 ª2012 Elsevier Ltd All rights reservedblockers (Giraudat et al., 1986; Hucho et al., 1986; Pedersen
et al., 1992; Taly et al., 2009). The presently available X-ray
data further clarify where channel blockers bind within the
pore: TEA and TBS near position 60 and lidocaine near positions
90 and 60, when bound to GLIC, and picrotoxin near positions20
and20, when bound toGluCl (Hibbs andGouaux, 2011) (Figure 4).
Altogether, ions and organic molecules bind at different
locations between positions20 and 90 within the pore according
to their size and their charge.
In summary, the currently available data on ion channel
permeation and selectivity demonstrate a remarkable conserva-
tion of structure/function relationships from prokaryotic to
eukaryotic pLGICs.
Allosteric ‘‘Modulatory’’ Sites
In addition to ligands acting at the orthosteric neurotransmitter
binding site and within the channel lumen, pLGICs are modu-
lated by a variety of molecules acting at several topographically
distinct allosteric sites. Typically, these molecules have low
intrinsic activity (though in a few cases act as full agonists) but
provide selective potentiation or inhibition of physiological
activity without directly affecting the ongoing signaling
processes. The major modulatory sites (Taly et al., 2009) are
located (1) at sites homologous to the orthosteric site but present
at nonagonist binding subunit interfaces, and (2) within the TMD,
which is the target of a wide variety of allosteric modulators
including ethanol and other alcohols, general anesthetics
(GAs), neurosteroids, lipids, and cholesterol as well as a variety
of synthetic compounds (Taly et al., 2009; Forman and Miller,
2011; Mihic et al., 1997; Li et al., 2006; Young et al., 2008;
Bertrand et al., 2008; daCosta et al., 2011; Gill et al., 2011).
This ‘‘transmembrane pharmacology’’ opens new opportunities
Figure 5. Binding Sites for Allosteric Modulators within the TMD
The ‘‘transmembrane pharmacology’’ illustrated by recent cocrystals of GLIC and GluCl, in which three distinct binding sites for allosteric modulation within the
TMD were identified: the intrasubunit and intersubunit cavities and the lipid bilayer interface. The first one was identified by cocrystals of GLIC with GAs and
confirmed by site-directed mutagenesis (Nury et al., 2011), the second one by the GluCl structure solved in complex with ivermectine (Hibbs and Gouaux, 2011)
and also suggested by molecular dynamics and site-directed mutagenesis, and the third one by the structure of wt GLIC in which lipids are seen in the electron
density maps (Bocquet et al., 2009).
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ingly, the recent open-channel structures of GLIC and GluCl
unravel, at atomic resolution, three distinct binding sites for
allosteric modulation within the TMD (Figure 5C).
Intrasubunit Cavity
The structures of GLIC bound to desflurane or propofol were
described at 3.2 A˚ resolution (Nury et al., 2011). Both GAs bind
to overlapping sites within a cavity already present in the apo
structure. The cavity is located in the upper part of the TMD, at
the center of the bundle of a helices of each subunit. X-ray elec-
tron density maps show that both GAs display relatively high
mobility in the cavity, a feature consistent with results of molec-
ular dynamics simulations which show that van der Waals inter-
actions are the main contributor to the binding energy. GLIC is
inhibited by both GAs (Weng et al., 2010), and the consequences
of mutations within the binding pocket are consistent with this
inhibitory effect (Nury et al., 2011). It is noteworthy that the
pharmacology of GLIC inhibition by GAs closely resembles
that of eukaryotic nAChRs, which are inhibited by GAs at clinical
concentrations and are especially sensitive to volatile GAs. The
cavity present in GLIC is thus a strong candidate for the nAChR
allosteric modulatory site. Furthermore, nAChRs are stronglyStrpotentiated, and sometimes directly activated, by a variety of
synthetic compounds (Krause et al., 1998; Young et al., 2008;
Bertrand et al., 2008; daCosta et al., 2011; Gill et al., 2011;).
Among these synthetic compounds, the positive modulatory
sites that PNU-120596 and LY-2087101 occupy on the a7
nAChR have been explored by mutagenesis. Mapping of
identified amino acids onto TnAChR or GLIC structures defines
the binding site at the center of the subunit, with a large overlap
with the GAs binding site identified from X-ray structure of GLIC
(Figure 5).
Intersubunit Cavity
Four recent structures of GluCl (Hibbs and Gouaux, 2011) were
all solved in complex with ivermectin. Ivermectin typically
behaves as an irreversible ligand that promotes allosteric poten-
tiation or inhibition depending on the type of pLGIC. With GluCl,
ivermectin behaves as an allosteric potentiator. It binds to the
upper part of the TMD at each subunit interface. This rather large
molecule contacts multiple residues from M2 and M3 of one
subunit and of M1 from the adjacent subunit. As compared to
GLIC, a helices M1 and M3 are significantly displaced, suggest-
ing that ivermectin not only stabilizes the active state but also
produces significant deformation of the transmembrane a helixucture 20, June 6, 2012 ª2012 Elsevier Ltd All rights reserved 947
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Interestingly, at the interior of the binding site, ivermectin estab-
lishes a hydrogen bond with Ser260 from M2. In the glycine
receptor and in the GABAA receptor the residues homologous
to GLIC Ser260 have been found to be a major determinant of
GAs and alcohols action (Mihic et al., 1997). In the GLIC struc-
ture, the equivalent residue faces an ‘‘intersubunit cavity’’
(Nury et al., 2011), which is also bordered by two residues found
to contribute, by affinity labeling, to the GA etomidate binding
site on the GABAA receptor (Li et al., 2006), yet competition
experiments show that GAs and alcohols bind to several distinct
sites (Li et al., 2010). In addition, neurosteroids do not inhibit but
rather potentiate etomidate labeling (Li et al., 2009), suggesting
that they bind to a distinct site, possibly an intrasubunit site
located in the upper part of M4 (Hosie et al., 2009; Jin and Stein-
bach, 2011). Molecular dynamics simulations show that the
intrasubunit cavity is accessible to ethanol in a model of the
glycine receptor based on GLIC (Murail et al., 2011) but not to
isoflurane when simulations were done in GLIC as a system
(Brannigan et al., 2010). In conclusion, although not yet directly
demonstrated, it is likely that the ivermectin potentiating binding
site overlaps with a common GA-alcohol binding site on
Gly-GABAA receptors that mediates part of their potentiating
effect. Consistent with these findings, in the chicken a7 nACh
receptor, mutations at two distinct locations facing the ion
channel [V251T(130) and L247T(90)] in M2 were initially shown
to alter the response to ivermectin (Krause et al., 1998).
Lipid Bilayer Interface
The structure of apo GLIC at 2.9 A˚ shows electron density at the
protein/lipid bilayer interface consistent with the presence of
three lipid molecules per subunit. Among the three lipid mole-
cules observed, the upper lipid is located just behind the GLIC
GA binding site and is significantly displaced in the propofol
GLIC structure (Nury et al., 2011). Because no exogenous lipids
were added during the detergent solubilization and protein
purification of GLIC, the observed molecules are, most likely,
endogenous, tightly bound native lipids that were carried
through the sample preparation process from the original
source. Lipids, free fatty acids, and steroids are known to
allosterically modulate pLGICs, notably nAChRs (Ferna´ndez
Nievas et al., 2008; daCosta and Baenziger, 2009; Nury et al.,
2011). These binding sites thus constitute likely candidates for
allosteric modulation by lipids as endogenous ligands.
Altogether, the recent structural data point to the existence of
three categories of allosteric binding sites, all located in the
upper part of the TMD, within and/or between subunits or at
the receptor lipid bilayer interface that are, again, remarkably
conserved from prokaryotic to eukaryotic pLGICs.
Models of Signal Transduction Mediated by pLGIC
In general, quantitative models proposed for drug action fall into
two main categories depending on the relationship between
ligand binding and the conformational change of the protein
mediating the response. They are best known as ‘‘sequential’’
(or ‘‘induced-fit’’) and ‘‘conformational selection’’ models.
The first model used by Del Castillo and Katz (1957) to fit their
electrophysiological recordings was, according to them,
inspired by Augustinsson’s work on the enzyme acetylcholines-
terase and based upon the simple assumption that the ‘‘receptor948 Structure 20, June 6, 2012 ª2012 Elsevier Ltd All rights reservedreacts in a two-step process,’’ the conformational change taking
place after, and only after, the ligand is bound to the target
protein. It strikingly resembles the ‘‘induced-fit’’ mechanism
independently postulated by Koshland (1959) for enzyme
activation (see also Koshland et al., 1966). This mechanism has
been used for decades to interpret electrophysiological data
(Colquhoun and Sakmann, 1985; Lape et al., 2008; Miller and
Smart, 2010).
On the other hand, the ligand conformational selection
hypothesis postulates that signal transduction is mediated by
a pre-established reversible equilibrium between a minimum of
two conformations (denoted T0 and R0) (possibly more) as set
by the isomerization constant L0 = [T0]/[R0] and the selective
stabilization by a given ligand of the particular state for which it
exhibits a preferential affinity (Monod et al., 1965) (MWCmodel).
Thismechanism has been extensively investigated and validated
with a variety of regulatory proteins (Changeux and Edelstein,
2005; Changeux, 2011, 2012).
The currently available knowledge about pLGIC is in general
agreement with the critical hypothesis of the MWC model that
the protein may spontaneously be present under several
different conformational states with different binding and
channel opening properties in the absence of ligand.
Strong structural and physiological evidence further support
the conformational selection scheme (Changeux and Edelstein,
2005, 2011; Auerbach, 2012). For instance, with muscle-type
nAChR, a wealth of electrophysiological studies (Revah et al.,
1991; Bertrand et al., 1997; Milone et al., 1997) including
single-channel channel recordings frommore than 1000mutants
(Purohit and Auerbach, 2010; Gupta and Auerbach, 2011; Jadey
et al., 2011) have shown that full channel openings may take
place spontaneously and with high frequency in the absence of
agonist, thus ruling out any sequential-induced-fit mechanism
(Jackson, 1984; Purohit and Auerbach, 2009). There are also
many spontaneous mutations known to cause congenital myas-
thenia and autosomal dominant nocturnal frontal lobe epilepsy
that are preferentially located either at the interface between
subunits or, within a given subunit, at the interface between rigid
domains of the receptor protein (Taly et al., 2006; Cadugan and
Auerbach, 2010). Only two discrete states in reversible equilib-
rium, a basal closed state and an active open state, suffice to
fit the data at variable ligand concentrations and with different
agonists (Gupta and Auerbach, 2011; Jadey et al., 2011).
While these studies are largely limited to the muscle-type
nAChR, the elementary MWC mechanism described here has
been reported to adequately match the available data for
prokaryotic GLIC and ELIC, which both show a dominant
single-channel conductance and are highly sensitive to gain-
of-function mutations within the ion channel domain (Bocquet
et al., 2007). It also accounts for glycine receptor and nAChR
data (Galzi et al., 1996a, Lynch, 2004). Most often, in LGIC,
electrophysiological recordings consistently show a unique, or
at least more abundant, unitary conductance following activa-
tion, though multiple conductances have been reported with
glycine and GABA receptors (Macdonald and Olsen, 1994;
Moroni et al., 2011). In the GABA receptor, mutations have
been identified in the loops of the neurotransmitter binding cleft
(at subunit interfaces) that generate spontaneously open chan-
nels (Boileau et al., 2002; Miller et al., 2008; Newell et al., 2004;
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chimeras (Eisele´ et al., 1993) show that, whereas the agonist
binding sites occupancy may contribute interdependently and
asymmetrically to open-channel stability, the coupling regions
between ECD and TMD contribute independently and symmetri-
cally to the conformational transition (Andersen et al., 2011). A
similar situation has been reported with a chimera in which the
ECD of the bacterial protein GLIC is fused to the TMD of the
human a1 glycine receptor (Duret et al., 2011).
The Conformational Transition of pLGICs
The basic function of pLGICs, from bacteria to brain, is to trans-
form the small agonists binding signal into an ion channel
opening. It was hypothesized, nearly 50 years ago, that in
membrane receptors, the signal transduction process is medi-
ated by a conformational transition referred to as allosteric
transition, which is analogous to that identified in regulatory
enzymes and described by the MWC model (Changeux, 1965;
Changeux et al., 1967; Edelstein et al., 1996; Karlin, 1967; Taly
et al., 2009). This hypothesis is supported by the structural
observations that the agonist binding site and the ion channel
are more than 50 A˚ apart (Figure 1A) and that allosteric modula-
tory sites involved in the signal transduction process are distrib-
uted all over the receptor molecule (Figure 5). Over the past
decades, allosteric transitions have been explored by mutagen-
esis coupled to electrophysiology and by affinity labeling, as well
as with several biophysical and computational methods
(for review, see Miller and Smart, 2010, Forman and Miller,
2011, Zheng and Auerbach, 2011). In this review, we focused
our analysis on recently published 3D structural data.
Early EM studies of TnAChR yielded images at 4–9 A˚ resolu-
tion, suggesting that channel opening involves an independent
rotation of individual M2 a helices accompanied by a kinked-
to-straight change of a helix conformation (Unwin, 1995; Unwin,
2005); this still needs to be validated. Subsequently, molecular
modeling was used to generate 3D structures of homomeric a7
receptor based on the then-available data from AChBP and
TnAChR (Taly et al., 2005) and the accessible conformational
states explored by the method of normal mode analysis (NMA)
(Brooks and Karplus, 1983; Go et al., 1983; Levitt et al., 1985).
The lowest frequency mode yielded a concerted movement
generating symmetrical deformations—or twist—of the structure
primarily at the quaternary level but also at the tertiary level, with
opposing rotations for the upper and lower domains, accompa-
nied with a reduction, though not full closure, of the pore size
(Taly et al., 2005).
The availability of three structures from GLIC, ELIC, and GluCl
offers new opportunities to examine the open/closed transition
at atomic resolution. Strikingly, the TMDs of GLIC, GluCl, and
that of TnAChR show a highly similar organization of the trans-
membrane a helices, generating a funnel-shaped channel
compatible with an open conformation (Figure 6A). In contrast,
the TMD of ELIC reveal a closed-channel conformation, with
an hydrophobic gate of less than 2 A˚ diameter in the upper
part of the pore as the consequence of a concerted tilt of M3
and M2, yet without a kinked-to-straight change of a helix
conformation (Bocquet et al., 2009).
In order to propose a global mechanism of pore opening, ELIC
and GLIC common core Ca atoms were compared (Figure 6B).StrThe comparison revealed a similar quaternary twist rotation in
the upper part of the pentamer. NMA confirmed this interpreta-
tion because it found that the lowest frequency mode with by-far
the highest contribution (29%) to the transition was a twist mode
(Bocquet et al., 2009). Moreover, GLIC to ELIC transition
involved a change in pore diameter (from 12 A˚ to 2 A˚) more
important than that suggested by NMA analysis (from 12 to
8 A˚). Therefore, the closing process in the GLIC to ELIC transition
is generated by a complex combination of higher frequency
modes that notably result in the concerted tilt of M2 and M3
out from the channel (Figure 6A). Such a mechanism is also
suggested by the interpolated elastic network model used to
compute the transition between ELIC and GLIC. In this analysis,
the sequence of structural events accompanying the transition
begins at the level of the orthosteric binding site, followed by
loop 2 and 7 motion ending with TMD a helices motions (Zheng
and Auerbach, 2011).
Interestingly, structural perturbations caused by performing,
independently, two single mutations or by introducing four
disulfide bridges unraveled a novel conformation of GLIC, which
corresponds globally to the open conformation but where the
upper-half of the M2 a helices is locally bent to close the pore
(Figure 6A). Functional and computational data support that
this ‘‘locally closed’’ or ‘‘LC’’ conformation contributes to the
GLIC function, possibly acting as an intermediate state in the
course of activation or desensitization (Figure 1B) (Prevost
et al., 2012). In addition, a 1 ms molecular dynamics simulation
of 200,000 atoms model of GLIC (Nury et al., 2010b), instantly
set to neutral pH to mimic agonist removal, showed a rapid
channel closure at the level of the hydrophobic furrow, followed
by a quaternary twist reorganization consistent with the NMA
analysis (Taly et al., 2005). Each subunit follows a two-step
transition, the first one within the first 50 ns and the second
one within the first 450 ns of simulation, suggesting a domino-
like or chain-reaction mechanism for channel closure
(Figure 6B). However, because of limited computational
resources, the simulation was stopped at 1 ms, when the transi-
tion was still incomplete. More studies are needed to assess
whether the same scenario is independent of the starting
conditions and holds when the transition is completed.
As illustrated by the long timescale simulation and suggested
by local comparison of GLIC and ELIC TMD, the three rings of
hydrophobic residues that border the upper part of the channel
constitute the gate that closes the pore in the basal state (with
a 2 A˚ diameter measured in ELIC) and is open in the active state
(with a 12 A˚ diameter measured in GLIC). This interpretation is
supported by extensive substituted cysteine accessibility anal-
ysis of both nAChR and GABAA receptors (Bali and Akabas,
2007), yet this does not preclude the presence of an additional
gate at a location closer to the cytoplasm, as suggested by
histidine scanning mutagenesis (Paas et al., 2005). The upper
part of the TMD ‘‘behind’’ the hydrophobic gate of the channel
would then be the region that undergoes the largest structural
reorganization in the TMD, making it a potential target for
efficient regulation. It is not then a surprise that the three binding
sites for allosteric modulation, the intrasubunit, intersubunit, and
surface binding sites (Figure 5), are located at the level of the
gate, with intrasubunit and intersubunit cavities in GLIC being
located at the same ‘‘level’’ along the pore axis, perpendicularucture 20, June 6, 2012 ª2012 Elsevier Ltd All rights reserved 949
Figure 6. Allosteric Mechanism of pLGICs in the Context of ELIC, GLIC-LC, and GLIC Structures
(A) Side view of ELIC, GLIC-LC, and GLIC in cartoon representation. Only two subunits are shown for clarity, and the ion permeation pathway (volume accessible
to the solvent) is shown in mesh.
(B) Superimposition of the common core of GLIC (green) and ELIC (red) highlighting the quaternary twist motion and the tertiary rotation of the b sandwich of the
ECD to go from one conformation to the other.
(C) Molecular dynamic simulation on GLIC (Nury et al., 2010b) set up at neutral pH witnesses a rapid closing of the pore as illustrated here by a snapshot of the
pore (represented in the lateral view by a grid, with only 2 M2 segments shown for clarity) at 0 ms (open) and 1.06 ms (closed through asymmetric motion of the M2
segments, notably from the S5 subunit).
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cavities are connected by a ‘‘linking tunnel’’ that might also
contribute to ethanol modulatory action on GLIC (Howard
et al., 2011).
The MWC theory deals with the thermodynamically stable end
states of the gating transition; however, the conformational reor-
ganization, which requires a few microseconds to be completed
(Chakrapani and Auerbach, 2005), involves progressive motions
and possibly intermediate states. For example, ECD movement
prior to that of TMD in the course of activation was suggested
from rate-equilibrium free energy (REFER) analysis of muscle-
type nAChR (Purohit and Auerbach, 2007). In addition, single-
channel electrophysiology experiments suggest that activation
involves an additional but still hypothetical intermediate ‘‘flip’’
state where the channel is closed and which would be stabilized
by agonists but only incompletely by partial agonists. This state950 Structure 20, June 6, 2012 ª2012 Elsevier Ltd All rights reservedwould be in equilibrium with the resting and active conformation
independently of the nature of the agonist. Incorporating such
a ‘‘flip’’ or ‘‘intermediate’’ state in schemes used to fit electro-
physiological data allowed a better agreement (Krashia et al.,
2011; Lape et al., 2008; Mukhtasimova et al., 2009) (Figure 1B).
Another distinguishing feature of the MWC model concerns
the transition states involved in the kinetics of the allosteric
transitions. Attention to this issue (Changeux and Edelstein,
2005) might be of some help in avoiding postulating improbable
reaction mechanisms, as recently illustrated for several pLGIC
(Lape et al., 2008).
In summary, the available structural and MD data unambigu-
ously demonstrate that in agreement with the MWC model,
a conformational transition(s) involving a reorganization of both
tertiary and quaternary structures mediates the activation
process in pLGIC. A quaternary twist mechanism that globally
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mechanism of signal transduction in the broad ensemble of
pLGICs (Figure 6B) and is also observedwith K+ channels (Cuello
et al., 2010a, 2010b; Shimizu et al., 2008), even though imper-
fectly symmetrical conformations are expected to occur in
hetero-oligomeric pLGICs (Unwin, 2005). Moreover, if the
MWC formalism adequately fits several of the critical physiolog-
ical and structural properties of pLGICs, the detailed analysis of
their conformational states, possible ‘‘intermediate states,’’ and
the dynamics of their transition may disclose unexpected future
scenarios.
Desensitization of pLGICs
Desensitization is a universal property of pLGICs, originally
demonstrated for the neuromuscular junction by Langley in
1905. When subjected to a prolonged exposure to agonists,
pLGICs undergo, in addition to activation, desensitization
processes typically illustrated by a multiexponential decay of
whole cell currents accompanied by an enhanced affinity for
agonists (and some antagonists) (Yamodo et al., 2010)
(Figure 1B). Functional studies suggest the occurrence of several
desensitized states that display a closed channel but are not
activatable by agonists, a feature also found for ELIC following
activation by cysteamine (Zimmermann and Dutzler, 2011) and
possibly for GLIC following activation by protons, although to
a much slower extent (Gonzalez-Gutierrez and Grosman, 2010).
Desensitization was analyzed by Katz and Thesleff (Katz and
Thesleff, 1957) in terms of a model that to some extent antici-
pates MWC and according to which the receptor spontaneously
exists in two forms: ‘‘effective’’ and ‘‘refractory,’’ the refractory
having a higher affinity for the drug than the effective. The model
accounts for most of the available physiological data, yet
the structural mechanisms underlying desensitization remain
unknown.
Extensive mutagenesis experiments have shown that the ‘‘hot
spots’’ for controlling desensitization are, among others, the
ECD (Bohler et al., 2001), the ECD-TMD interface (Bouzat
et al., 2008), the hydrophobic rings that border the upper part
of the channel (Revah et al., 1991), and the loop linking the M1
and M2 segment (Breitinger et al., 2001). Recent voltage-clamp
fluorimetry on the glycine receptor suggests that during the
transition from the active to the desensitized state, the ECD
does not undergo large structural motions as monitored by
a fluorescent probe incorporated at six different locations; the
ECD-TMD interface undergoes large motions instead, suggest-
ing that desensitization might underlie a local reorganization of
the TMD (Wang and Lynch, 2011). Reorganization in the course
of desensitization in the upper part of the TMD is supported by
time-resolved affinity labeling experiments with the hydrophobic
probe 3-(trifluoromethyl)-3-(m-iodophenyl) diazirine (TID) (For-
man and Miller, 2011; Yamodo et al., 2010). TID labeling reveals
that during fast desensitization, a conformation change occurs in
the channel lumen at the level of M2–90, but none takes place in
the regions of the d-subunit’s M2–M3 loop and the interior of its
M1–M4 a-helix bundle until slow desensitization occurs. These
data suggest that there are physically distinct gates for channel
opening and slow and fast desensitization (Figure 1B).
In short, discrete structural differences exist between desensi-
tized and resting/open conformations at both the ion channelStrand ligand binding site. In particular, the desensitized conforma-
tion is known to display a very high affinity for both agonists and
antagonists. Structural and functional characterization of these
diverse conformations is urgently needed.
Hetero-Oligomerization and the Functional Diversity
of Eukaryotic pLGIC
In eukaryotic pLGICs, an important functional diversification
results from gene duplication and combinatorial association of
the resulting homologous subunits into pseudosymmetrical
hetero-oligomers. In contrast to the relatively versatile interaction
at the ECD-TMD interface, the heterologous interaction that
mediate the assembly of subunits to form the pentameric oligo-
mers are governed by rather stringent rules. For example, more
than 40 genes code for pentameric receptor subunits in the
human genome and the number of possible combinations is
very high, yet they self-assemble into strictly defined phyloge-
netic subfamilies to form the Gly, GABAA, nACh and 5HT3 recep-
tors. Even more, the assembly rules within subfamilies are rather
complex; for example, in the nAChR subfamily, certain subunits
only assemble into obligatory hetero-oligomers of fixed stoichi-
ometry (like muscle type a1-g-a1-d-b1), and some assemble
exclusively as homopentamers (like a7) while others (like a4, a5,
a6, b2, b4) assemble with stoichiometries that may vary from
one brain area to the other (Changeux, 2010; Gotti et al., 2006).
It is noteworthy that the available structures concern homo-
meric receptors, while the family contains many heteromeric
receptors. Analysis of such receptors, in particular the a2bgd
nAChR (Bruhova and Auerbach, 2010; Lee and Sine, 2005) or
artificial chimeras (Andersen et al., 2011), points to a differential
contribution of the subunits to the gating process, with ‘‘agonist
binding’’ subunits playing a key role.
Furthermore, one of the most clinically relevant categories of
allosteric modulatory sites, present in some heteromeric
pLGICs, is homologous to the orthosteric site but located at
nonagonist binding interfaces. This is the case for sites that
bind benzodiazepines, which act as allosteric potentiators
and are used as anxiolytics, muscle relaxant, and sedatives. In
GABAA receptors exemplified by the major brain subtype
a1b2g2, GABA binding sites are located at the ba interface,
while the ga interface carries binding sites for benzodiazepines
(Atack, 2011).
In addition, numerous allosteric sites within the ECD or at the
ECD-TMD interface, especially for those binding divalent ions
such as Ca2+ (Galzi et al., 1996b; Le Nove`re et al., 2002) or
Zn2+ (Hsiao et al., 2006) have been described for nAChRs and
other pLGICs (Bertrand and Gopalakrishnan, 2007; Franks,
2008; Harris et al., 2008; Taly et al., 2009; Perkins et al., 2010;
Forman and Miller, 2011; Pandya and Yakel, 2011).
Up to now, all of the above-mentioned allosteric sites have
been identified in eukaryotic receptors and not yet reported
with prokaryotic pLGIC. Important outcomes are thus antici-
pated from future structural and functional studies of hetero-
oligomeric pLGICs.
Conclusion: Consequences for Drug Design
This review illustrates the remarkable structural and functional
similarities between bacterial pLGICs and brain receptors. The
contributions of pLGICs to bacterial physiology remainucture 20, June 6, 2012 ª2012 Elsevier Ltd All rights reserved 951
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cyanobacteria Gloeobacter violaceus has the unique property
of carrying out photosynthesis at its inner membrane, which
involves conversion of light energy into a proton gradient from
both sides of the membrane. A proton-gated ion channel at
this level might possibly sense the proton concentration of the
periplasmic space and thus be critical for this process (Bocquet
et al., 2007). Concerning ELIC, Erwinia chrysanthemi is a plant
pathogen and GABA is a major metabolite that accumulates
rapidly in plant tissues in response to stress. It is conceivable
that a bacterial GABAA receptor might be useful for bacteria to
adapt to plant infections (Zimmermann and Dutzler, 2011).
Last, many bacterial species are known to establish cooperative
‘‘social’’ interaction through a mechanism called quorum
sensing, in which bacterial cells communicate with each other
by releasing, sensing, and responding to small diffusible signal
molecules (Li and Tian, 2012). Bacterial pLGICs might possibly
contribute to these ‘‘social interactions’’ and thus already be
viewed as authentic models for neurotransmitter receptors. As
a consequence, they may usefully serve for drug design to
neuronal pLGICs known to play key roles in the excitatory and
inhibitory pathways within the central and peripheral nervous
system of higher organisms.
An important outcome of the available structural data
concerns the symmetry properties of the pLGIC molecule.
Known bacterial pLGICs are homo-oligomers with a C5
rotational axis of symmetry, but in neuronal pLGICs, hetero-
oligomers frequently occur. For a given pLGIC category, multiple
subunit genes are present in the genome and their products
possess the ability to associate into defined oligomeric
structures whose composition may vary with tissue and/or brain
distribution. Because the principal ligand binding sites in ECD
and TMD (especially for pharmacologically active compounds)
are most often located at subunits boundaries, the resulting
diversity is particularly considerable. This creates new opportu-
nities for drug design but also substantial challenges for the
targeting of drugs to particular circuits in the brain.
In the past, agonist and antagonist drugs were designed to fit
a rigid site in a single conformation within the so-called ‘‘compet-
itive-isosterism’’ paradigm (Black and Prichard, 1973; Bovet,
1959). By contrast, the allosteric scheme implies that agonists
and antagonists, as well as positive and negative ‘‘allosteric
modulators,’’ select and stabilize structurally different conforma-
tions thatmay bemodeled for the active, resting, and also desen-
sitized states exploiting the considerable amount of data rapidly
emerging from structural and molecular dynamics studies, in
particular with prokaryotic pLGICs. The MWC statement that
diverse conformations may spontaneously exist in the absence
of a ligand opens the possibility of designing drugs that enhance
or block an ongoing activity. It also predicts that mutations, by
altering the unliganded equilibrium between discrete conforma-
tional states, may cause constitutive receptor activation or inhibi-
tion, causing what may be referred to as ‘‘receptor disorders.’’ACKNOWLEDGMENTS
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